These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 29356625)
1. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis. Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625 [TBL] [Abstract][Full Text] [Related]
2. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Pampalakis G; Mitropoulos K; Xiromerisiou G; Dardiotis E; Deretzi G; Anagnostouli M; Katsila T; Rentzos M; Patrinos GP Hum Mutat; 2019 Apr; 40(4):361-373. PubMed ID: 30556231 [TBL] [Abstract][Full Text] [Related]
3. Further development of biomarkers in amyotrophic lateral sclerosis. Blasco H; Vourc'h P; Pradat PF; Gordon PH; Andres CR; Corcia P Expert Rev Mol Diagn; 2016 Aug; 16(8):853-68. PubMed ID: 27275785 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers for amyotrophic lateral sclerosis. Bowser R; Cudkowicz M; Kaddurah-Daouk R Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741 [TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. Krüger T; Lautenschläger J; Grosskreutz J; Rhode H Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563 [TBL] [Abstract][Full Text] [Related]
6. Protein biomarkers for amyotrophic lateral sclerosis. Ryberg H; Bowser R Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics in amyotrophic lateral sclerosis: how far can it take us? Blasco H; Patin F; Madji Hounoum B; Gordon PH; Vourc'h P; Andres CR; Corcia P Eur J Neurol; 2016 Mar; 23(3):447-54. PubMed ID: 26822316 [TBL] [Abstract][Full Text] [Related]
8. From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis. Castelli L; Vasta R; Allen SP; Waller R; Chiò A; Traynor BJ; Kirby J Int Rev Neurobiol; 2024; 176():209-268. PubMed ID: 38802176 [TBL] [Abstract][Full Text] [Related]
9. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642 [TBL] [Abstract][Full Text] [Related]
10. New insights into the gene expression associated to amyotrophic lateral sclerosis. Recabarren-Leiva D; Alarcón M Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis. Ricci C; Marzocchi C; Battistini S Cells; 2018 Nov; 7(11):. PubMed ID: 30463376 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development. Wang L; Zhang L Neurol Sci; 2020 Dec; 41(12):3569-3577. PubMed ID: 33006054 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis. Krokidis MG Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479 [TBL] [Abstract][Full Text] [Related]
14. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844 [TBL] [Abstract][Full Text] [Related]
15. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. Ekegren T; Hanrieder J; Bergquist J J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436 [TBL] [Abstract][Full Text] [Related]
16. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease. Kolarcik C; Bowser R Mol Diagn Ther; 2006; 10(5):281-92. PubMed ID: 17022691 [TBL] [Abstract][Full Text] [Related]
17. [Biomarkers for amyotrophic lateral sclerosis]. Tokuda T Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065 [TBL] [Abstract][Full Text] [Related]
18. The 'Omics' of Amyotrophic Lateral Sclerosis. Caballero-Hernandez D; Toscano MG; Cejudo-Guillen M; Garcia-Martin ML; Lopez S; Franco JM; Quintana FJ; Roodveldt C; Pozo D Trends Mol Med; 2016 Jan; 22(1):53-67. PubMed ID: 26691296 [TBL] [Abstract][Full Text] [Related]
19. Identification of Apo B48 and other novel biomarkers in amyotrophic lateral sclerosis patient fibroblasts. Narayan M; Seeley KW; Jinwal UK Biomark Med; 2016 May; 10(5):453-62. PubMed ID: 27141953 [TBL] [Abstract][Full Text] [Related]
20. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Oeckl P; Weydt P; Thal DR; Weishaupt JH; Ludolph AC; Otto M Acta Neuropathol; 2020 Jan; 139(1):119-134. PubMed ID: 31701227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]